Data di Pubblicazione:
2019
Citazione:
Arrhythmogenic cardiomyopathy: what blood can reveal? / I. Stadiotti, G. Pompilio, A.S. Maione, C.A. Pilato, Y. D'Alessandra, E. Sommariva. - In: HEART RHYTHM. - ISSN 1547-5271. - 16:3(2019), pp. 470-477.
Abstract:
Blood, serum and plasma represent accessible sources of data about physiological and pathologic status. In arrhythmogenic cardiomyopathy (ACM), circulating nucleated cells are routinely used for detection of germinal genetic mutations. In addition, different biomarkers have been proposed for diagnostic purposes and for monitoring disease progression, including inflammatory cytokines, markers of myocardial dysfunction and damage, and microRNAs. This review summarizes the current information that can be retrieved from the blood of ACM patients and considers the future prospects. Improvements in current knowledge of circulating factors may provide noninvasive means to simplify and improve the diagnosis, prognosis prediction, and management of ACM patients.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Arrhythmogenic right ventricular cardiomyopathy; Biomarkers; Blood; Genetics; Heart failure; Inflammation; Plasma; Serum; microRNA
Elenco autori:
I. Stadiotti, G. Pompilio, A.S. Maione, C.A. Pilato, Y. D'Alessandra, E. Sommariva
Link alla scheda completa:
Link al Full Text: